Difference between revisions of "Example orders for Degarelix (Firmagon) in prostate cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth" to "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:200%"> Hello!<br> We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br> Please help us by filling it out!<br> '''Link:''' http://j.mp/2BlBaoQ </span> |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | |
| − | |||
| − | < | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 17: | Line 10: | ||
===Example order set #1=== | ===Example order set #1=== | ||
====Loading dose==== | ====Loading dose==== | ||
| − | *[[Degarelix (Firmagon)]] 240 mg SC once on day 1. | + | *[[Degarelix (Firmagon)]] 240 mg SC once on day 1. Give as two 120 mg injections with a 27 gauge, 1 1/4 inch needle. Administer at a 45 degree angle SC into the periumbilical tissue while holding the tissue in a tented up fashion. |
'''start maintenance doses 28 days after loading dose''' | '''start maintenance doses 28 days after loading dose''' | ||
====Maintenance doses==== | ====Maintenance doses==== | ||
| − | *[[Degarelix (Firmagon)]] 80 mg SC once on day 1. | + | *[[Degarelix (Firmagon)]] 80 mg SC once on day 1. Give as one 80 mg injection with a 27 gauge, 1 1/4 inch needle. Administer at a 45 degree angle SC into the periumbilical tissue while holding the tissue in a tented up fashion. |
'''28-day cycles''' | '''28-day cycles''' | ||
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:51, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Degarelix (Firmagon)
Published regimens and references can be found on the prostate cancer page.
Example order set #1
Loading dose
- Degarelix (Firmagon) 240 mg SC once on day 1. Give as two 120 mg injections with a 27 gauge, 1 1/4 inch needle. Administer at a 45 degree angle SC into the periumbilical tissue while holding the tissue in a tented up fashion.
start maintenance doses 28 days after loading dose
Maintenance doses
- Degarelix (Firmagon) 80 mg SC once on day 1. Give as one 80 mg injection with a 27 gauge, 1 1/4 inch needle. Administer at a 45 degree angle SC into the periumbilical tissue while holding the tissue in a tented up fashion.
28-day cycles